But payment remains a mystery.The biggest news at the annual CMS clinical laboratory
Fee Schedule (CLFS) public meeting just might be what wasn't said. Although participants were invited to propose pricing for molecular pathology codes (81200-81408) if they believed the services should be paid under the CLFS, the silence was deafening. Interpretation: By not proposing molecular pathology payment rates at the CLFS meeting, some major industry and professional groups indicated their preference for payment on the Physician Fee Schedule (PFS).Background: Diffusing potentially protracted debate about fee schedule placement for molecular pathology, CMS moderator Glenn McGuirk directed participants to respond to the calendar year (CY) 2013 PFS proposed rule if they had "recommendations on whether these codes represent clinical diagnostic laboratory tests that should be paid under the CLFS or services that should be paid under the PFS." Get Up to Date on New CodesCPT® 2012 added 101 new [...]